This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Identify Which Dividend Aristocrats ETF Has Highest Expense Ratio and discuss implications for costs and performance.
27,586 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
Nu Holdings has fallen sharply, with the stock down 37% from its 52-week high. This guide explains what an investor s...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
Bitwise CIO Matt Hougan argues that Strategy's STRC selloff reflects end-of-cycle deleveraging preceding a bitcoin bo...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Moody’s Analytics now sees a near-even chance of a U.S. recession within the next year, as energy shocks and a coolin...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
Ripple faced renewed selling on May 28 as major tokens breached supports, pushing the ripple (xrp) price down and sig...
As bond markets flash warnings and oil risk climbs from Gulf tensions, a leading wall street strategist warns that th...